We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Program Designed to Provide High-Performance Computing Cluster Systems for Bioinformatics Research

By LabMedica International staff writers
Posted on 25 Jan 2015
Print article
Dedicated Computing (Waukesha, WI, USA), a global technology company, reported that it will be participating in the Intel Cluster Ready program to deliver integrated high-performance computing cluster solutions to the life sciences market.

Powered by Intel Xeon processors, Dedicated Computing is providing a range of purpose-built analytics and storage clusters for use in bioinformatics research. Dedicated Computing’s HPC cluster, built upon Intel Cluster Ready architecture, will provide a fully integrated and optimized cluster.

From entry level, compact clusters, featuring four multi-core homogeneous nodes, to those with hundreds of heterogeneous computing nodes, and combined with 20 Terabytes to multiple Petabytes of object store, these scalable solutions will be able to support the massive amounts of data that needs to be analyzed, interpreted, and stored. These integrated cluster solutions contain securely maintained open source software stacks and cluster management that are designed to accelerate time-to-market, minimize expensive validation and verification and enable 24 x 7-hour x 365-day system monitoring for increased uptime.

“We are excited to join the Intel Cluster Ready program—working together, we can deliver leading edge HPC clustering technology tailored to Life Sciences research applications like genome analysis that will soon lead to personalized medicine,” said Jeff Durst, director, healthcare and life science solutions, Dedicated Computing. “Our healthcare expertise and design capabilities help support the needs of our customers with flexible and innovative technology.”

“Participation in the Intel Cluster Ready program makes it easier and faster to realize the performance advantages of HPC clusters,” said Stephen Wheat, Sr. director for HPC systems solutions at Intel. “The assurance of application and component interoperability from the moment a cluster powers on is critical in the markets Dedicated Computing serves. We are excited to have Dedicated Computing join the program and look forward to working with them to help advance research and drive innovation in the Life Sciences market.”

Related Links:

Dedicated Computing
Intel Cluster Ready


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Automated Blood Typing System
IH-500 NEXT
New
Centrifuge
Centrifuge 5430/ 5430 R
New
Chemistry Analyzer
MS100

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.